Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Abeona Therapeutics
Abeona Therapeutics
(ABEO)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Prademagene zamikeracel
epidermolysis bullosa dystrophica
,
epidermolysis bullosa
Bevifimod
hepatocellular carcinoma
,
liver neoplasms
,
renal insufficiency
,
leukemia
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
carcinoma
,
malaria
,
glioma
,
neoplasms
,
colorectal neoplasms
,
renal cell carcinoma
,
squamous cell carcinoma of head and neck
,
glioblastoma
,
gliosarcoma
,
lung neoplasms
,
soft tissue neoplasms
,
residual neoplasm
,
t-cell lymphoma cutaneous
,
melanoma
,
neoplasm metastasis
,
breast neoplasms
,
non-small-cell lung carcinoma
,
t-cell lymphoma peripheral
,
obesity
,
cardiovascular diseases
,
dyslipidemias
,
sleep apnea syndromes
,
weight loss
,
crohn disease
,
ankylosing spondylitis
,
ulcerative colitis
,
psoriasis
,
behcet syndrome
,
juvenile arthritis
,
rheumatoid arthritis
,
hypertension
,
connective tissue diseases
,
autoimmune diseases
,
rheumatic diseases
Fluoroquinolone
healthy volunteers/patients
,
diabetes mellitus
,
pharmacokinetics
,
major depressive disorder
,
neoplasms
,
long qt syndrome
,
alzheimer disease
,
asthma
,
chronic obstructive pulmonary disease
,
lung diseases
,
respiration disorders
,
emphysema
,
bronchiolitis
,
rheumatoid arthritis
,
non-alcoholic fatty liver disease
,
alcoholic fatty liver
,
sepsis
,
septic shock
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use